Ahmet Bacaksiz Selected Research

N,N'- diethylene- N''- (5- methyl- 1,3,4- thiadiazol- 2- yl)phosphoramide (S 261)

10/2014

Association between serum cystatin C levels and coronary slow flow.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ahmet Bacaksiz Research Topics

Disease

12	Myocardial Infarction 01/2019 - 01/2010
6	ST Elevation Myocardial Infarction 01/2019 - 07/2008
3	Heart Failure 09/2015 - 02/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2015 - 03/2011
2	Coronary Artery Disease (Coronary Atherosclerosis) 09/2018 - 04/2015
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2015 - 03/2013
2	Hypertension (High Blood Pressure) 05/2014 - 01/2010
2	Thrombosis (Thrombus) 10/2013 - 08/2013
1	Inflammation (Inflammations) 04/2021
1	Disease Susceptibility (Diathesis) 01/2019
1	Familial Thoracic 1 Aortic Aneurysm 03/2016
1	Dextrocardia 03/2016
1	Ischemic Stroke 07/2015
1	Atherosclerosis 04/2015
1	Acute Coronary Syndrome 12/2014
1	Renal Artery Obstruction (Renal Artery Stenosis) 04/2014
1	Necrosis 02/2014
1	Stable Angina 08/2013
1	Ventricular Remodeling 08/2013
1	Atrial Fibrillation 06/2013
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2013
1	Infarction (Infarctions) 02/2013
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2013
1	Neoplasms (Cancer) 01/2012
1	Cardiotoxicity 01/2012
1	Atrial Remodeling 12/2010
1	Stroke (Strokes) 01/2010
1	Masked Hypertension 01/2010
1	Endocarditis 07/2009
1	Hematoma 09/2008

Drug/Important Bio-Agent (IBA)

4	Sirtuin 1IBA 01/2019 - 01/2014
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2014
2	AntioxidantsIBA 04/2021 - 01/2019
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2019 - 04/2015
2	C-Reactive ProteinIBA 01/2015 - 03/2013
2	Biomarkers (Surrogate Marker)IBA 12/2014 - 02/2014
2	Simendan (Levosimendan)IBA 06/2014 - 02/2014
2	Spironolactone (Aldactone)FDA LinkGeneric 08/2013 - 12/2010
2	Indicators and Reagents (Reagents)IBA 01/2012 - 07/2008
1	Sulfhydryl Compounds (Thiols)IBA 04/2021
1	urotensin IIIBA 04/2021
1	Oxidants (Oxidizing Agents)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 09/2018
1	SirtuinsIBA 09/2018
1	EnzymesIBA 09/2015
1	Cathepsin DIBA 09/2015
1	EndopeptidasesIBA 09/2015
1	omega-Chloroacetophenone (Mace)IBA 09/2015
1	Coenzyme A (CoA)IBA 04/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2015
1	Oxidoreductases (Dehydrogenase)IBA 04/2015
1	N,N'- diethylene- N''- (5- methyl- 1,3,4- thiadiazol- 2- yl)phosphoramide (S 261)IBA 10/2014
1	Dobutamine FDA LinkGeneric 06/2014
1	Mineralocorticoid Receptor AntagonistsIBA 05/2014
1	Interleukin-1beta (Interleukin 1 beta)IBA 02/2014
1	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2014
1	S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA 08/2013
1	Atrial Natriuretic Factor (ANF)IBA 07/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012
1	CD40 Ligand (CD40L)IBA 03/2011
1	Glycoproteins (Glycoprotein)IBA 03/2011
1	HDL CholesterolIBA 01/2010
1	mahuang-tangIBA 01/2010
1	HDL LipoproteinsIBA 01/2010
1	CoagulaseIBA 07/2009
1	Enoxaparin (Lovenox)FDA LinkGeneric 09/2008

Therapy/Procedure

5	Percutaneous Coronary Intervention 09/2013 - 12/2012
3	Stents 10/2013 - 02/2013
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2018 - 06/2013
2	Sympathectomy (Sympathectomies) 05/2014 - 04/2014
1	Therapeutics 03/2016
1	Catheters 07/2015
1	Thrombectomy 07/2015
1	Renal Dialysis (Hemodialysis) 01/2013
1	Erythrocyte Transfusion 12/2012
1	Mitral Valve Annuloplasty 07/2009